Mechanisms and sites of ocular action of 7-hydroxy-2- dipropylaminotetralin: A dopamine3 receptor agonist

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 3, 2000, Pages 710-716

  Chu, Eugenia ^a   Chu, Teh Ching ^a   Potter, David E ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; 2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR FLOW; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; INTRAOCULAR HYPOTENSION; MALE; NONHUMAN; POSTGANGLIONIC NERVE; PRIORITY JOURNAL; SYMPATHECTOMY; SYMPATHETIC NERVE;

ANIMALS; AQUEOUS HUMOR; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE; FEMALE; IMMUNOHISTOCHEMISTRY; INDANS; INTRAOCULAR PRESSURE; MALE; RABBITS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SYMPATHECTOMY; TETRAHYDRONAPHTHALENES;

EID: 0034049765     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. J Pharmacol Exp Ther 287:187-197.
2. Brubaker R (1989) Measurement of aqueous flow by fluorophotometry, in Glaucoma (Ritch R, Schield MB and Krupin R eds) pp 337-344, CV Mosby Co., St. Louis, MO.
3. Campbell WR and Potter DE (1995) Centrally mediated ocular hypotension: Potential role of imidazoline receptors. Ann NYAcad Sci 763:463-485.
4. 1A receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits. Exp Eye Res 69:587-593.
5. Chu E, Chu TC and Potter DE (1999a) Potential sites of action of TNPA: A dopamine-2 receptor agonist. Exp Eye Res 69:611-616.
6. Chu TC, Ogidigben MJ and Potter DE (1999b) 8OH-DPAT-induced ocular hypotension: Sites and mechanisms of action. Exp Eye Res 69:227-238.
7. 2 receptors. Curr Eye Res 15:943-950.
8. Civelli O, Bunzow JR and Grandy DK (1993) Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 33:281-307.
9. Cole DF (1977) Secretion of the aqueous humor. Exp Eye Res 25 (Suppl):161-176.
10. Crosson CE (1995) Adenosine receptor activation modulates intraocular pressure in rabbits. J Pharmacol Exp Ther 273:320-326.
11. 3 receptor ligand. Eur J Pharmacol 249:R9-R10.
12. Gingrich JA and Caron MG (1993) Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 16:299-321.
13. Gregory DS, Aviado DG and Sears ML (1985) Cervical ganglionectomy alters the circadian rhythm of intraocular pressure in New Zealand white rabbits. Curr Eye Res 4:1273-1279.
14. Hall DA and Strange PG (1999) Comparison of the ability of dopamine receptor agonists to inhibit forskolin-stimulated adenosine 3′5′-cyclic monophosphate (cAMP) accumulation via D2L (long isoform) and D3 receptors expressed in Chinese hamster ovary (CHO) cells. Biochem Pharmacol 58:285-289.
15. Landwehrmeyer B, Mengod G and Palacios JM (1993) Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur J Neurosci 5:145-153.
16. 3 dopamine receptor: Neurobiology and potential clinical relevance. Pharmacol Rev 49:231-252.
17. Levesque D, Diaz J, Pilon C, Martres MP, Giros B, Souil E, Schott D, Morgat JL, Schwartz JC and Sokoloff P (1992) Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H] hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 89:8155-8159.
18. Mekki QA, Hassan SM and Turner P (1983) Bromocriptine lowers intraocular pressure without affecting blood pressure. Lancet 1:1250-1251.
19. 2) agonist, 2, 10, 11-trihydroxy-N-n-propylnoraporphine. J Pharmacol Exp Ther 267:822-827.
20. Ogidigben M, Chu TC and Potter DE (1994) Ocular action of moxonidine: A possible role for imidazoline receptors. J Pharmacol Exp Ther 269:897-904.
21. Potter DE (1995) Do dopamine and dopamine receptors have roles in modulating function in the anterior segment?: The evidence, in Progress in Retinal and Eye Research (Osborne NN and Chader GJ eds) pp 103-111, Elsevier Sciences Ltd., New York.
22. Potter DE, Crosson CE, Heath AR and Ogidigben MJ (1990) Review: Alpha2 and DA2 agonists as antiglaucoma agents: Comparative pharmacology and clinical potential. J Ocul Pharmacol 6:251-257.
23. Potter DE, Ogidigben MJ and Chu TC (1998) Lisuride acts at multiple sites to induce ocular hypotension and mydriasis. Pharmacology 57:249-260.
24. Prunte C and Flammer J (1995) The novel dopamine D-1 antagonist and D-2 agonist, SDZ GLC-756, lowers intraocular pressure in healthy human volunteers and in patients with glaucoma. Ophthalmology 102:1291-1297.
25. Rogoz R and Dziedzicka-Wasylewska M (1999) Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding: An autoradiographic analysis. Naunyn-Schmiedeberg's Arch Pharmacol 359:178-186.
26. Sears M, Mizuno K, Cintron C, Alter A and Sherk T (1966) Changes in outflow facility and content of norepinephrine in iris and ciliary processes of albino rabbits after cervical ganglionectomy. Invest Ophthalmol 5:312-318.
27. Yablonski ME, Zimmerman TJ, Waltman SR and Becker B (1978) A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp Eye Res 27:135-142.
28. 3 Receptors modulate evoked dopamine release from slices of rat nucleus accumbens via muscarinic receptors, but not from the striatum. J Pharmacol Exp Ther 291:994-998.
29. Yamada S, Yokoo H and Nishi S (1994) Differential effects of dopamine agonist on evoked dopamine release from slices of striatum and nucleus accumbens in rats. Brain Res 648:176-179.